-+ 0.00%
-+ 0.00%
-+ 0.00%

Skye Bioscience receives Nasdaq notice for falling below $10 million equity minimum

PUBT·05/15/2026 20:01:29
Listen to the news
Skye Bioscience receives Nasdaq notice for falling below $10 million equity minimum
  • Skye Bioscience received Nasdaq notice of noncompliance with Global Market Listing Rule 5450(b)(1)(A) after reporting stockholders’ equity of 9.01 million in its quarterly filing for period ended March 31, 2026, below 10 million minimum.
  • Nasdaq gave 45 days, until June 29, 2026, to submit plan to regain compliance; acceptance could allow extension to Nov. 9, 2026, to demonstrate equity at or above 10 million.
  • Notice does not immediately affect listing or trading; shares continue to trade on Nasdaq Global Market under symbol SKYE.
  • Failure to win plan approval could trigger delisting process, though appeal rights would keep shares listed during appeal.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Skye Bioscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-035535), on May 15, 2026, and is solely responsible for the information contained therein.